Design Therapeutics, Inc. (DSGN) DCF Valuation

Design Therapeutics, Inc. (DSGN) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Design Therapeutics, Inc. (DSGN) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Enhance your investment choices with the Design Therapeutics, Inc. (DSGN) DCF Calculator! Dive into real financial data, adjust growth projections and expenses, and instantly observe how these modifications affect the intrinsic value of Design Therapeutics, Inc. (DSGN).


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 -72.9 -100 0 0 -43.23 -43.23 -43.23 -43.23 -43.23
EBITDA -.1 -8.3 -35.7 -62.8 -66.3 .0 .0 .0 .0 .0
EBITDA, % -16666.67 -3683628.32 100 100 100 20 20 20 20 20
Depreciation 1.9 .0 .1 .5 .5 .0 .0 .0 .0 .0
Depreciation, % 228776.98 2212.39 100 100 100 100 100 100 100 100
EBIT -2.0 -8.3 -35.8 -63.3 -66.9 .0 .0 .0 .0 .0
EBIT, % -245443.65 -3685840.71 100 100 100 20 20 20 20 20
Total Cash .1 36.1 384.1 330.4 281.8 .0 .0 .0 .0 .0
Total Cash, percent .0 16.0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .1 1.1 1.4
Account Receivables, % 0 4424.78 100 100 100
Inventories .0 .1 1.3 -1.1 .0 .0 .0 .0 .0 .0
Inventories, % 0 47345.13 100 100 100 80 80 80 80 80
Accounts Payable 2.5 1.4 1.6 3.0 1.9 .0 .0 .0 .0 .0
Accounts Payable, % 297242.21 619026.55 100 100 100 100 100 100 100 100
Capital Expenditure .0 -.1 -1.5 -.9 -.3 .0 .0 .0 .0 .0
Capital Expenditure, % 0 -33628.32 100 100 100 -20 -20 -20 -20 -20
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -2.0 -8.3 -35.8 -58.6 -66.9 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF 2.3 -9.6 -38.3 -56.3 -69.1 -.5 .0 .0 .0 .0
WACC, % 13.03 13.03 13.03 13.02 13.03 13.03 13.03 13.03 13.03 13.03
PV UFCF
SUM PV UFCF -.4
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value 0
Net Debt -18
Equity Value 18
Diluted Shares Outstanding, MM 56
Equity Value Per Share 0.32

What You Will Receive

  • Authentic DSGN Financial Data: Pre-loaded with Design Therapeutics’ historical and projected figures for accurate analysis.
  • Completely Customizable Template: Easily adjust key inputs such as revenue growth, WACC, and EBITDA %.
  • Instant Calculations: Watch as Design Therapeutics’ intrinsic value updates in real-time with your modifications.
  • Expert Valuation Tool: Tailored for investors, analysts, and consultants aiming for precise DCF outcomes.
  • Intuitive Design: Clear layout and straightforward instructions suitable for all skill levels.

Key Features

  • Comprehensive DCF Model: Features both unlevered and levered DCF valuation frameworks tailored for Design Therapeutics, Inc. (DSGN).
  • WACC Tool: A pre-configured Weighted Average Cost of Capital calculator with adjustable parameters.
  • Customizable Forecast Inputs: Adjust growth projections, capital investments, and discount rates as needed.
  • Integrated Financial Ratios: Evaluate profitability, leverage, and operational efficiency ratios specific to Design Therapeutics, Inc. (DSGN).
  • Interactive Dashboard and Visuals: Graphical representations that encapsulate essential valuation indicators for straightforward analysis.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review Design Therapeutics, Inc.'s (DSGN) pre-filled financial data and forecasts.
  3. Step 3: Modify key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Observe the DCF model update in real-time as you adjust assumptions.
  5. Step 5: Analyze the outputs and leverage the results for investment decisions.

Why Choose This Calculator for Design Therapeutics, Inc. (DSGN)?

  • Accuracy: Leverages real Design Therapeutics financials for precise data.
  • Flexibility: Built to allow users to easily test and adjust inputs.
  • Time-Saving: Eliminate the need to create a DCF model from the ground up.
  • Professional-Grade: Crafted with the expertise and usability expected at the CFO level.
  • User-Friendly: Intuitive design makes it accessible for users without extensive financial modeling skills.

Who Should Use This Product?

  • Investors: Evaluate Design Therapeutics, Inc.'s (DSGN) potential for investment by estimating its fair value.
  • CFOs: Utilize a sophisticated DCF model for accurate financial reporting and analysis related to Design Therapeutics, Inc. (DSGN).
  • Consultants: Easily customize the template for valuation reports tailored to clients interested in Design Therapeutics, Inc. (DSGN).
  • Entrepreneurs: Discover financial modeling techniques employed by leading biotech firms, including Design Therapeutics, Inc. (DSGN).
  • Educators: Implement it as a resource for teaching valuation methodologies relevant to the biotech industry, like that of Design Therapeutics, Inc. (DSGN).

What the Template Contains

  • Operating and Balance Sheet Data: Pre-filled Design Therapeutics, Inc. (DSGN) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
  • WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
  • DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
  • Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
  • Key Ratios: Includes profitability, leverage, and efficiency ratios for Design Therapeutics, Inc. (DSGN).
  • Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.

No products were found matching.